Expanded Test Report Summary
The product Nandrolone Phenylpropionate 100mg, manufactured by Noxy Labs under batch 15TNX1, was analyzed by Janoshik Analytical. The analysis revealed a measured concentration of 110.56 mg/ml, exceeding the labeled claim by 10.56%. This suggests the product is slightly overdosed compared to the manufacturer’s stated specification.
The testing process commenced on 1 August 2024, the sample was received on 6 August 2024, and the analysis was finalized on 15 August 2024.
Detailed Report
Product Overview
- Manufacturer: Noxy Labs
- Product Name: Nandrolone Phenylpropionate 100mg
- Batch Number: 15TNX1
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #46710
- Testing Ordered: 1 August 2024
- Sample Received: 6 August 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Noxy Labs (Manufacturer)
- Analysis Paid For By: Noxy Labs
Testing Results
- Specification (Label Claim): 100 mg/ml
- Measured Concentration: 110.56 mg/ml
- Accuracy: 110.56% (10.56% above the label claim)
Verification Details
- Verification URL: https://janoshik.com/tests/46710_QDZHDACGTHKQ
- Originally Published: https://thinksteroids.com/community/posts/3324084/
Evaluation of Manufacturer-Submitted Testing
The test results indicate an overdosage of 10.56%, which may reflect inconsistencies in production or intentional overdosing to account for degradation over time. While this may provide a margin of safety, it also highlights the importance of independent verification to ensure product consistency and user safety across different batches.
Conclusion
The independent analysis of Nandrolone Phenylpropionate 100mg (batch 15TNX1) by Noxy Labs shows a measured concentration of 110.56 mg/ml, exceeding the labeled specification by 10.56%. This result demonstrates strong product quality, but users are encouraged to cross-reference with third-party analyses for broader reliability assessments.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-funded testing may involve potential biases, such as selective sample submissions. These findings are limited to the tested batch and may not represent the entire product line. Cross-referencing with independent third-party testing is recommended for a comprehensive evaluation.
